Holen Sie sich die Stockscreener-App
16.84
4.73%
0.76
Handel nachbörslich:
16.92
0.08
+0.48%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Kenvue Stock Rebound: A Buying Opportunity? - timothysykes.com
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Bullish flow in Kenvue Inc with shares up 4.7% - TipRanks
Kenvue’s Resurgence: New Opportunities or Risks? - StocksToTrade
November 28th Options Now Available For Kenvue (KVUE) - Nasdaq
US Republicans and Democrats split on party lines on Trump's Tylenol-autism claimKFF poll - MarketScreener
Is Kenvue Inc. stock a buy in volatile marketsEntry Point & Daily Oversold Bounce Ideas - newser.com
Chart based analysis of Kenvue Inc. trends2025 Valuation Update & Precise Buy Zone Tips - newser.com
Is Kenvue Inc. (J4D) stock a buy for dividend portfoliosStock Surge & Weekly High Return Stock Opportunities - newser.com
Kenvue Inc. $KVUE Shares Sold by Belpointe Asset Management LLC - MarketBeat
Comparing Kenvue Inc. in custom built stock radarsDay Trade & Free Verified High Yield Trade Plans - newser.com
Is Kenvue Inc. a candidate for recovery play2025 Price Targets & Weekly High Return Opportunities - newser.com
QRG Capital Management Inc. Buys 29,813 Shares of Kenvue Inc. $KVUE - MarketBeat
B of A Securities Maintains Kenvue (KVUE) Buy Recommendation - Nasdaq
UBS Maintains Kenvue (KVUE) Neutral Recommendation - Nasdaq
Donald Trump’s Tylenol Warning Makes Kenvue Stock (KVUE) an Opportunity in Disguise - TipRanks
Kenvue (KVUE): Exploring Valuation After Recent Share Price Weakness - Yahoo Finance
Kenvue’s SWOT analysis: stock faces Tylenol headwinds amid strategic shift - Investing.com
Kenvue’s SWOT analysis: stock faces Tylenol headwinds amid strategic shift By Investing.com - Investing.com UK
Kenvue (NYSE:KVUE) Price Target Lowered to $21.00 at Bank of America - MarketBeat
Moderately bullish activity in Kenvue Inc with shares down 0.59% - TipRanks
Kenvue Becomes Oversold - Nasdaq
How the Narrative Around Kenvue Is Shifting Amid Legal and Regulatory Headwinds - Yahoo Finance
Kenvue price target lowered to $21 from $25 at BofA - TipRanks
UBS Adjusts Kenvue Price Target to $17 From $23, Maintains Neutral Rating - MarketScreener
Kenvue price target lowered to $17 from $23 at UBS - TipRanks
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump - The Motley Fool
Citigroup Adjusts Price Target on Kenvue to $17 From $20, Maintains Neutral Rating - MarketScreener
WESPAC Advisors LLC Invests $544,000 in Kenvue Inc. $KVUE - MarketBeat
Near 52-Week Low, Should You Buy Kenvue Stock? - The Globe and Mail
KLP Kapitalforvaltning AS Has $22.45 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Simplicity Wealth LLC Purchases Shares of 24,210 Kenvue Inc. $KVUE - MarketBeat
Did Trump’s Tylenol Pregnancy Warning Just Shift Kenvue's (KVUE) Brand Risk Profile? - simplywall.st
Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks - MSN
Bullish flow in Kenvue Inc with shares up 3.22% - TipRanks
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again - Sahm
Is Kenvue Inc. stock a buy before new product rolloutJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Visual trend scoring systems applied to Kenvue Inc.Stop Loss & AI Driven Price Forecasts - newser.com
Kenvue Inc. $KVUE Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Why Is Kenvue Stock Falling, and Is It a Buying Opportunity? - The Motley Fool
What insider purchases suggest about Kenvue Inc. stockMarket Performance Summary & AI Powered Market Trend Analysis - newser.com
How strong is Kenvue Inc. stock earnings growth2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
Why retail traders accumulate Kenvue Inc. stockJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
Will Kenvue Inc. stock outperform benchmarksTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Why analysts raise outlook for Kenvue Inc. (J4D) stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Why millennials buy Kenvue Inc. stockMarket Trend Review & Reliable Entry Point Alerts - newser.com
Litigation risks for Kenvue: focus shifts to U.S. appeals court - Investing.com
Is Kenvue Inc. stock near bottom after decline2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com
Assessing Kenvue (KVUE) Valuation: Is the Stock Priced for a Potential Turnaround? - simplywall.st
Market Movers: Metsera and Apple surge, Kenvue falters on Tylenol troubles - MSN
Truist Financial Corp Has $16.46 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Moody’s changes Kenvue outlook to negative amid operational challenges - Investing.com
Is Kenvue Inc. stock poised for growthTrend Reversal & AI Enhanced Execution Alerts - newser.com
Lawmakers dump Tylenol stock before autism controversy - Vermont Daily Chronicle
Goldman Sachs Sticks To Its Hold Rating For Kenvue, Inc. (KVUE) - Barchart.com
How Kenvue Inc. (J4D) stock performs in easing cycles2025 Short Interest & Real-Time Volume Triggers - newser.com
Barclays Lowers PT on Kenvue (KVUE) to $17 From $20, Keeps an Equal Weight Rating - Yahoo Finance
Is Kenvue Inc. stock among top earnings playsTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Is There an Opportunity in Kenvue After Recent 24% Share Price Drop? - simplywall.st
Cornell Pochily Investment Advisors Inc. Acquires 19,609 Shares of Kenvue Inc. $KVUE - MarketBeat
0.07%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):